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Background:  Increased left ventricular myocardial oxidative metabolism is associated with poor prognosis in patients with heart failure. 
Reduction of increased oxidative metabolism is one of the therapeutic targets. Elevated pulmonary arterial pressure may increase right ventricular 
(RV) oxidative metabolism in patients with pulmonary hypertension (PH). However, this possibility has not been studied. The aims of the current study 
were to evaluate RV oxidative metabolism and its correlation with pulmonary arterial pressure (PAP) in patients with PH using 11C-acetate PET.
Methods:  Fifteen patients with stable World Health Organization (WHO) class 2 to class 3 PH (WHO class 2=7 and class 3=8 patients, age 
44.8±14.3 years, mean PAP (mPAP): 42.9±15.6 mmHg, PV resistance: 656.5±245.3) and five age-matched controls (age 35.4±11.5 years) 
underwent dynamic 11C-acetate PET. Ventricular function [LV ejection fraction (EF) and RVEF] was assessed using magnetic resonance imaging. 
Mean PAP was measured using right heart catheterization in PH patients. Dynamic 11C-acetate PET was used to simultaneously measure oxidative 
metabolism (kmono) for both LV and RV. Corrected RV oxidative metabolism (RVOx) was calculated as: RVOx = RV/LV kmono ratio.
Results:  RVEF was significantly lower in patients with PH (RVEF 34.3±9.4% vs. 42.6±3.5%, P=0.04), while LVEF was similar in the two groups 
(LVEF 59.9±7.8% vs. 52.9±4.2%, ns). There was no significant difference in LV kmono between the PH and control groups (0.057±0.001 min-1 
vs. 0.054±0.004 min-1, P=0.597). On the other hand, PH patients showed higher RV kmono than did control patients (0.047±0.010 min-1 vs. 
0.030±0.008 min-1, P=0.010). Therefore, RVOx was also increased in patients with PH (82.7±7.8% vs. 55.1±11.6%, P=0.0035). RV oxidative 
metabolism was correlated with mPAP (r=0.56, p=0.029). 
Conclusions:  Despite reduced RV function, RV oxidative metabolism increased in correlation with increased mPAP in patients with WHO class 
2 to class 3 PH. RV oxidative metabolism derived using 11C-acetate PET reflects the severity of RV pressure overload. A reduction in RV oxidative 
metabolism may be a new therapeutic target in patients with WHO class 2 to class 3 PH.
